Capsugel

Capsugel, established in 1931, is a prominent entity within the global pharmaceutical and healthcare sectors. Now operating as a Lonza company, it specializes in the design, development, and manufacturing of advanced dosage forms. The firm provides comprehensive solutions for biopharmaceutical and consumer health industries, focusing on innovative drug delivery systems, encapsulation technologies, and specialized polymer applications. Its technical capabilities span the entire drug development lifecycle, from initial screening and process development to large-scale commercial manufacturing.

The organization maintains a robust operational footprint with 5 locations globally. With a workforce of 5,000-10,000 employees, Capsugel leverages extensive technical expertise to support complex clinical and commercial manufacturing requirements. Meet Capsugel's team to understand the organizational structure and leadership driving these specialized development services. The company utilizes advanced filling equipment and integrated onsite expertise to meet stringent regulatory standards, ensuring that every project adheres to global quality certifications, including halal and kosher requirements.

Capsugel competes with major industry players such as Catalent, Patheon Pharma Services, and Piramal Pharma Solutions. Its product portfolio includes hard capsules, inhalation drug delivery, and integrated onsite expertise. By maintaining rigorous GMP certification and specialized milling and filling equipment, the company addresses critical needs in the global drug development lifecycle. Its focus on secondary packaging, drug intermediates, and formulation optimization allows it to serve a diverse client base, maintaining a strong market position in the competitive landscape of pharmaceutical manufacturing and contract services.